EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C18H23NO3S |
| Net Charge | 0 |
| Average Mass | 333.453 |
| Monoisotopic Mass | 333.13986 |
| SMILES | CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1 |
| InChI | InChI=1S/C18H23NO3S/c1-18(9-3-2-4-10-18)12-22-14-7-5-13(6-8-14)11-15-16(20)19-17(21)23-15/h5-8,15H,2-4,9-12H2,1H3,(H,19,20,21) |
| InChIKey | YZFWTZACSRHJQD-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Role: | insulin-sensitizing drug An agent which overcomes insulin resistance by activation of the peroxisome proliferator activated receptor gamma (PPAR-gamma). |
| Applications: | insulin-sensitizing drug An agent which overcomes insulin resistance by activation of the peroxisome proliferator activated receptor gamma (PPAR-gamma). antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| ciglitazone (CHEBI:64227) has role antineoplastic agent (CHEBI:35610) |
| ciglitazone (CHEBI:64227) has role insulin-sensitizing drug (CHEBI:50864) |
| ciglitazone (CHEBI:64227) is a aromatic ether (CHEBI:35618) |
| ciglitazone (CHEBI:64227) is a thiazolidinone (CHEBI:48891) |
| IUPAC Name |
|---|
| 5-{4-[(1-methylcyclohexyl)methoxy]benzyl}-1,3-thiazolidine-2,4-dione |
| INNs | Source |
|---|---|
| ciglitazonum | ChemIDplus |
| ciglitazona | ChemIDplus |
| ciglitazone | ChemIDplus |
| Synonym | Source |
|---|---|
| (+-)-5-(p-((1-Methylcyclohexyl)methoxy)benzyl)-2,4-thiazolidinedione | ChemIDplus |
| Manual Xrefs | Databases |
|---|---|
| D03493 | KEGG DRUG |
| Ciglitazone | Wikipedia |
| LSM-1911 | LINCS |
| Registry Numbers | Sources |
|---|---|
| Reaxys:3623680 | Reaxys |
| CAS:74772-77-3 | ChemIDplus |
| Citations |
|---|